Related references
Note: Only part of the references are listed.Rapid and Specific Detection, Molecular Epidemiology, and Experimental Virulence of the O16 Subgroup within Escherichia coli Sequence Type 131
James R. Johnson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Virulence Patterns in a Murine Sepsis Model of ST131 Escherichia coli Clinical Isolates Belonging to Serotypes O25b:H4 and O16:H5 Are Associated to Specific Virotypes
Azucena Mora et al.
PLOS ONE (2014)
Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010
Ritu Banerjee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans
Aylin Colpan et al.
CLINICAL INFECTIOUS DISEASES (2013)
Four Main Virotypes among Extended-Spectrum-β-Lactamase-Producing Isolates of Escherichia coli O25b:H4-B2-ST131: Bacterial, Epidemiological, and Clinical Characteristics
Jorge Blanco et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli
James R. Johnson et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
The Epidemic of Extended-Spectrum-β-Lactamase-Producing Escherichia coli ST131 Is Driven by a Single Highly Pathogenic Subclone, H30-Rx
Lance B. Price et al.
MBIO (2013)
Characterization of Globally Spread Escherichia coli ST131 Isolates (1991 to 2010)
Angela Novais et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms
Akke K. Van der Bij et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England
Tarek M. Gibreel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Molecular Epidemiology over an 11-Year Period (2000 to 2010) of Extended-Spectrum β-Lactamase-Producing Escherichia coli Causing Bacteremia in a Centralized Canadian Region
Gisele Peirano et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Comparison of Escherichia coli ST131 Pulsotypes, by Epidemiologic Traits, 1967-2009
James R. Johnson et al.
EMERGING INFECTIOUS DISEASES (2012)
Clinical and Molecular Characteristics of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Causing Bacteremia in the Rotterdam Area, Netherlands
Akke K. van der Bij et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from Rio de Janeiro, Brazil
G. Peirano et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa
Gisele Peirano et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
High Prevalence of ST131 Isolates Producing CTX-M-15 and CTX-M-14 among Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates from Canada
Gisele Peirano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals
Gisele Peirano et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4
Gisele Peirano et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Molecular Characteristics of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates Causing Bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of Clone ST131 as a Cause of Community-Acquired Infections
Johann D. D. Pitout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004
James R. Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains
Olivier Clermont et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan
Kunikazu Yamane et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern
Johann D. D. Pitout et al.
LANCET INFECTIOUS DISEASES (2008)
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Marie-Helene Nicolas-Chanoine et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15
Teresa M. Coque et al.
EMERGING INFECTIOUS DISEASES (2008)
Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary health region: Emergence of CTX-M-15-producing isolates
Johann D. D. Pitout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme
Chi Hye Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The CTX-M β-lactamase pandemic
Rafael Canton et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
qnr Prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States
A. Robicsek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: Converting the national databases to the new size standard
SB Hunter et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Rapid and simple determination of the Escherichia coli phylogenetic group
O Clermont et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)
Share Paper
